Suppr超能文献

细胞周期蛋白依赖性激酶19在p53反应中的非激酶依赖性作用

A Kinase-Independent Role for Cyclin-Dependent Kinase 19 in p53 Response.

作者信息

Audetat K Audrey, Galbraith Matthew D, Odell Aaron T, Lee Thomas, Pandey Ahwan, Espinosa Joaquin M, Dowell Robin D, Taatjes Dylan J

机构信息

Department of Chemistry and Biochemistry, University of Colorado, Boulder, Colorado, USA.

Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, Colorado, USA.

出版信息

Mol Cell Biol. 2017 Jun 15;37(13). doi: 10.1128/MCB.00626-16. Print 2017 Jul 1.

Abstract

The human Mediator complex regulates RNA polymerase II transcription genome-wide. A general factor that regulates Mediator function is the four-subunit kinase module, which contains either cyclin-dependent kinase 8 (CDK8) or CDK19. Whereas CDK8 is linked to specific signaling cascades and oncogenesis, the cellular roles of its paralog, CDK19, are poorly studied. We discovered that osteosarcoma cells (SJSA) are naturally depleted of CDK8 protein. Whereas stable CDK19 knockdown was tolerated in SJSA cells, proliferation was reduced. Notably, proliferation defects were rescued upon the reexpression of wild-type or kinase-dead CDK19. Comparative RNA sequencing analyses showed reduced expression of mitotic genes and activation of genes associated with cholesterol metabolism and the p53 pathway in CDK19 knockdown cells. SJSA cells treated with 5-fluorouracil, which induces metabolic and genotoxic stress and activates p53, further implicated CDK19 in p53 target gene expression. To better probe the p53 response, SJSA cells (shCDK19 versus shCTRL) were treated with the p53 activator nutlin-3. Remarkably, CDK19 was required for SJSA cells to return to a proliferative state after nutlin-3 treatment, and this effect was kinase independent. These results implicate CDK19 as a regulator of p53 stress responses and suggest a role for CDK19 in cellular resistance to nutlin-3.

摘要

人类中介体复合物在全基因组范围内调节RNA聚合酶II转录。调节中介体功能的一个通用因子是四亚基激酶模块,它包含细胞周期蛋白依赖性激酶8(CDK8)或CDK19。虽然CDK8与特定信号级联反应和肿瘤发生有关,但其旁系同源物CDK19的细胞作用却鲜有研究。我们发现骨肉瘤细胞(SJSA)天然缺乏CDK8蛋白。虽然SJSA细胞能够耐受稳定的CDK19敲低,但细胞增殖会减少。值得注意的是,野生型或激酶失活的CDK19重新表达后可挽救增殖缺陷。比较RNA测序分析表明,在CDK19敲低的细胞中,有丝分裂基因的表达降低,而与胆固醇代谢和p53途径相关的基因被激活。用5-氟尿嘧啶处理SJSA细胞,5-氟尿嘧啶会诱导代谢和基因毒性应激并激活p53,这进一步表明CDK19参与p53靶基因的表达。为了更好地探究p53反应,用p53激活剂nutlin-3处理SJSA细胞(shCDK19与shCTRL)。值得注意的是,SJSA细胞在nutlin-3处理后恢复到增殖状态需要CDK19,且这种作用不依赖于激酶。这些结果表明CDK19是p53应激反应的调节因子,并提示CDK19在细胞对nutlin-3的抗性中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1870/5472832/20ba583d0b8e/zmb9991015120001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验